TANG CAPITAL MANAGEMENT LLC

13F Portfolio Filings

Most recent 13F
Q2 2026
Also reports for
Based on a Q2 2026 13F notice
13D/G filings
13D on 8 securities, 13G on 36 securities
Location
San Diego, CA
CIK
0001232621
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q2 2026 41 2,201,787 AUPH, SYRE, MIRM, KNSA 13F-HR 8/14/2026 000121465926010416
Q1 2026 51 1,968,963 AUPH, CELC, MIRM, LKFT 13F-HR 5/15/2026 000121465926006493
Q4 2025 75 2,024,360 AUPH, LKFT, PTCT, CELC 13F-HR 2/17/2026 000121465926002015
Q3 2025 194 2,597,852 TARS, LKFT, AUPH, PTCT 13F-HR 11/14/2025 000121465925016677
Q2 2025 200 1,978,390 LKFT, TARS, AUPH, IMCR 13F-HR 8/14/2025 000121465925012272
Q1 2025 202 1,807,581 TARS, LKFT, AUPH, DVAX 13F-HR 5/15/2025 000121465925007882
Q4 2024 183 1,511,333 TARS, AUPH, LKFT, EOLS 13F-HR 2/14/2025 000121465925002812
Q3 2024 154 1,399,857 EOLS, TARS, AUPH, VRDN 13F-HR 11/14/2024 000121465924019100
Q2 2024 128 981,874 TARS, EOLS, KALV, MIRM 13F-HR 8/14/2024 000121465924014706
Q1 2024 99 960,446 TARS, EOLS, KALV, ANAB 13F-HR 5/15/2024 000121465924009328
Q4 2023 123 1,082,240 MRTX, IMGN, TARS, KALV 13F-HR 2/14/2024 000121465924002878
Q3 2023 106 708,683 TARS, MIRM, ANAB, KALV 13F-HR 11/14/2023 000121465923015104
Q2 2023 99 679,261 ANAB, TARS, MIRM, IMGN 13F-HR 8/14/2023 000121465923011255
Q1 2023 103 671,118 ANAB, BLUE, MIRM, EOLS 13F-HR 5/15/2023 000121465923007174
Q4 2022 89 688,313 ANAB, ALT, BLUE, TARS 13F-HR 2/14/2023 000121465923002405
Q3 2022 95 815,421 ANAB, BHVN, BLUE, TARS 13F-HR 11/14/2022 000121465922013682
Q2 2022 67 659,035 ANAB, VERU, ALT, BHVN 13F-HR 8/15/2022 000121465922010178
Q1 2022 53 499,884 ANAB, ITCI, LJPC, ITOS 13F-HR 5/16/2022 000121465922006993
Q4 2021 29 497,219 ANAB, HRTX, RCKT, LJPC 13F-HR 2/14/2022 000121465922002553
Q3 2021 20 481,665 HRTX, RCKT, ANAB, ODTC 13F-HR 11/15/2021 000121465921011775
Q2 2021 16 502,375 HRTX, RCKT, ANAB, ODTC 13F-HR 8/16/2021 000121465921008646
Q1 2021 11 355,428 RCKT, ANAB, APVO, ODTC 13F-HR 5/17/2021 000121465921005555
Q4 2020 11 655,025 ODTC, RCKT, APVO, ANAB 13F-HR 2/16/2021 000121465921001968
Q3 2020 20 552,680 ODTC, RCKT, HRTX, BHVN 13F-HR 11/16/2020 000121465920009570
Q2 2020 21 1,028,604 ODTC, BHVN, RCKT, ANAB 13F-HR 8/14/2020 000121465920007161
Q1 2020 25 712,166 ODTC, RLMD, RCKT, HRTX 13F-HR 5/15/2020 000121465920004698
Q4 2019 17 836,969 ODTC, HRTX, RCKT, RLMD 13F-HR 2/14/2020 000121465920001509
Q3 2019 12 584,477 ODTC, HRTX, LJPC, RCKT 13F-HR 11/14/2019 000121465919007196
Q2 2019 10 739,969 ODTC, HRTX, LJPC, RCKT 13F-HR 8/14/2019 000121465919005293
Q1 2019 9 542,747 ODTC, HRTX, RCKT, LJPC 13F-HR 5/15/2019 000121465919003586
Q4 2018 8 435,875 ODTC, HRTX, RCKT, LJPC 13F-HR 2/14/2019 000121465919001183
Q3 2018 4 612,464 ODTC, HRTX, LJPC, RCKT 13F-HR 11/14/2018 000121465918007147
Q2 2018 4 788,960 HRTX, ODTC, LJPC, RCKT 13F-HR 8/14/2018 000121465918005500
Q1 2018 4 680,444 ODTC, HRTX, LJPC, RCKT 13F-HR 5/15/2018 000121465918003768
Q4 2017 4 631,178 ODTC, HRTX, LJPC, RXDX 13F-HR 2/14/2018 000121465918001258
Q3 2017 5 327,505 HRTX, LJPC, RXDX, BMRN 13F-HR 11/14/2017 000121465917006703
Q2 2017 5 281,744 HRTX, LJPC, RXDX, BMRN 13F-HR 8/14/2017 000121465917005098
Q1 2017 5 276,666 HRTX, LJPC, RXDX, BMRN 13F-HR 5/15/2017 000121465917003412
Q4 2016 7 187,513 HRTX, LJPC, RXDX, OPKO HEALTH INC 13F-HR 2/14/2017 000121465917001142
Q3 2016 7 241,111 HRTX, LJPC, RXDX, OPKO HEALTH INC 13F-HR 11/15/2016 000121465916014680
Q2 2016 12 224,444 HRTX, LJPC, RXDX, OPKO HEALTH INC 13F-HR 8/15/2016 000121465916013257
Q1 2016 15 219,600 HRTX, LJPC, OPKO HEALTH INC, BMRN 13F-HR 5/16/2016 000121465916011634
Q4 2015 5 252,020 HRTX, LJPC, OPKO HEALTH INC, BMRN 13F-HR 2/16/2016 000121465916009582
Q3 2015 6 271,185 HRTX, LJPC, OPK, BMRN 13F-HR 11/16/2015 000121465915007805
Q2 2015 6 329,583 HRTX, LJPC, BRLI, OPKO HEALTH INC 13F-HR 8/14/2015 000121465915006097
Q1 2015 8 188,008 HRTX, LJPC, OPKO HEALTH INC, BMRN 13F-HR 5/15/2015 000121465915004043
Q4 2014 9 182,383 HRTX, LJPC, SLXP, OPKO HEALTH INC 13F-HR 1/27/2015 000121465915000607
Q3 2014 12 193,002 SLXP, HRTX, PDL BIOPHARMA INC, OPKO HEALTH INC 13F-HR 11/14/2014 000121465914007736
Q2 2014 12 215,933 HRTX, PDL BIOPHARMA INC, SLXP, OPKO HEALTH INC 13F-HR 8/14/2014 000121465914005936
Q1 2014 13 206,207 HRTX, PDL BIOPHARMA INC, SLXP, OPKO HEALTH INC 13F-HR 5/15/2014 000121465914003661
Q4 2013 13 142,994 PDL BIOPHARMA INC, SLXP, OPKO HEALTH INC, MRTX 13F-HR 2/14/2014 000121465914001230

13D and 13G Filings

All 13D and 13G filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each security where the latest filing since 12/18/2024 is a 13D, newest first.

Issuer % of Class Filed
Aurinia Pharmaceuticals Inc. 13D/A
AUPH · 05156V102
 10.0% 6/4/2026
Event 6/2/2026
ITeos Therapeutics, Inc. 13D/A
ITOS · 46565G104
 100.0% 9/3/2025
Event 8/29/2025
Cargo Therapeutics, Inc. 13D/A
CRGX · 14179K101
 100.0% 8/21/2025
Event 8/19/2025
Allakos Inc. 13D/A
ALLK · 01671P100
 100.0% 5/19/2025
Event 5/15/2025
Pliant Therapeutics, Inc. 13D
PLRX · 729139105
 9.6% 3/10/2025
Event 3/3/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Kezar Life Sciences, Inc. 13D/A
KZR · 49372L209
 0% 5/13/2026
Event 5/11/2026
HilleVax, Inc. 13D/A
HLVX · 43157M102
 0% 9/19/2025
Event 9/17/2025
Acelyrin, Inc. 13D/A
SLRN · 00445A100
 0% 5/23/2025
Event 5/21/2025

36 other securities where the latest filing is a 13G, the newest filed 10/27/2026. View all